Molycorp (NYSE:MCP)‘s stock had its “neutral” rating restated by analysts at Goldman Sachs Group Inc. in a research report issued to clients and investors on Friday, StockRatingsNetwork reports. They currently have a $5.00 price objective on the stock. Goldman Sachs Group Inc.’s target price would indicate a potential upside of 5.04% from the company’s current price.
MCP has been the subject of a number of other recent research reports. Analysts at Zacks downgraded shares of Molycorp from a “neutral” rating to an “underperform” rating in a research note to investors on Thursday. They now have a $4.60 price target on the stock. Separately, analysts at Cowen and Company raised their price target on shares of Molycorp from $5.13 to $8.60 in a research note to investors on Tuesday, October 15th. They now have a “market perform” rating on the stock. Finally, analysts at Robert W. Baird reiterated a “neutral” rating on shares of Molycorp in a research note to investors on Tuesday, October 15th. They now have a $200.00 price target on the stock, up previously from $8.00. One analyst has rated the stock with a sell rating, seven have given a hold rating, two have given a buy rating and one has issued a strong buy rating to the company. The stock has an average rating of “Hold” and a consensus target price of $29.26.
Molycorp (NYSE:MCP) traded up 3.15% on Friday, hitting $4.91. The stock had a trading volume of 6,173,506 shares. Molycorp has a 52 week low of $4.61 and a 52 week high of $11.81. The stock’s 50-day moving average is $6.12 and its 200-day moving average is $6.31. The company’s market cap is $926.1 million.
Molycorp (NYSE:MCP) last released its earnings data on Thursday, November 7th. The company reported ($0.27) EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.29) by $0.02. The company had revenue of $149.10 million for the quarter, compared to the consensus estimate of $162.59 million. During the same quarter in the prior year, the company posted ($0.05) earnings per share. The company’s quarterly revenue was down 27.3% on a year-over-year basis. Analysts expect that Molycorp will post $-0.93 EPS for the current fiscal year.
Molycorp, Inc provides Rare Earths and Molybdenum products to companies. The Company’s rare earth products comprise of bastnasite, cerium, europium, lanthanum, neodymium, praseodymium, yttrium, and other lanthanides.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.